Merck & Co, Indian Firms On Tackling Supply Chain Risks And A Hijack

Visibility And Digitization Are Key

Merck & Co. executive outlines how the company could sustain a “compliant supply performance” amid the pandemic, while senior officials from Sun Pharma, Cipla, Zydus Cadila and Biocon shared insights on coping with supply chain turbulence and moving away from over-dependence on China for starting materials.

Shipping & Map image

Senior executives from Merck & Co., Inc. and several leading Indian pharma firms have shared insights around how they built supply chain resilience against the backdrop of the general turmoil during the early days of COVID-19. The experiences were also dotted with interesting real world vignettes, including the hijack of a pharma cargo truck in India.

Addressing the recently concluded BioAsia 2021 virtual event, Sanat Chattopadhyay, executive vice-president and president, Merck Manufacturing Division, noted the pandemic had unleashed a “tsunami” of changes, causing an inflection point in the life sciences segment

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from COVID-19

More from In Vivo